Home/Filings/4/0001179110-11-005346
4//SEC Filing

Nelson Arlin D 4

Accession 0001179110-11-005346

CIK 0000856982other

Filed

Mar 21, 8:00 PM ET

Accepted

Mar 22, 5:39 PM ET

Size

18.1 KB

Accession

0001179110-11-005346

Insider Transaction Report

Form 4
Period: 2011-03-21
Nelson Arlin D
Chief Operating Officer
Transactions
  • Sale

    Common Stock, No Par Value

    2011-03-21$18.86/sh8,890$167,6710 total
  • Exercise/Conversion

    Common Stock, No Par Value

    2011-03-21$7.61/sh+8,890$67,6538,890 total
  • Exercise/Conversion

    Non-qualified Stock Options (right to buy)

    2011-03-218,8900 total
    Exercise: $7.61From: 2001-12-08Exp: 2011-12-08Common Stock (8,890 underlying)
Holdings
  • Common Stock, No Par Value

    (indirect: By 401(k))
    743
  • Non-qualified Stock Options (right to buy)

    Exercise: $21.67From: 2003-12-13Exp: 2013-12-13Common Stock (3,500 underlying)
    3,500
  • Non-qualified Stock Options (right to buy)

    Exercise: $15.03From: 2004-12-18Exp: 2014-12-18Common Stock (10,000 underlying)
    10,000
  • Non-qualified Stock Options (right to buy)

    Exercise: $13.81From: 2004-06-10Exp: 2014-06-10Common Stock (1,500 underlying)
    1,500
  • Non-qualified Stock Options (right to buy)

    Exercise: $12.14From: 2005-12-28Exp: 2015-12-28Common Stock (10,000 underlying)
    10,000
  • Non-qualified stock options (right to buy)

    Exercise: $14.41From: 2009-05-21Exp: 2015-05-21Common Stock (25,000 underlying)
    25,000
  • Non-qualified Stock Options (right to buy)

    Exercise: $9.74From: 2003-02-06Exp: 2013-02-06Common Stock (8,889 underlying)
    8,889
  • Non-qualified Stock Options (right to buy)

    Exercise: $12.13From: 2008-06-27Exp: 2014-06-27Common Stock (20,000 underlying)
    20,000
Footnotes (4)
  • [F1]Represents plan holdings as of March 21, 2011.
  • [F2]Becomes exercisable in equal annual installments of 20% commencing 06/27/08.
  • [F3]Becomes exercisable in equal annual installments of 20% commencing 05/21/09.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.85 to $18.92, inclusive. The reporting person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Issuer

MERIT MEDICAL SYSTEMS INC

CIK 0000856982

Entity typeother

Related Parties

1
  • filerCIK 0001382939

Filing Metadata

Form type
4
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 5:39 PM ET
Size
18.1 KB